Cargando…

iPSC Bioprinting: Where are We at?

Here, we present a concise review of current 3D bioprinting technologies applied to induced pluripotent stem cells (iPSC). iPSC have recently received a great deal of attention from the scientific and clinical communities for their unique properties, which include abundant adult cell sources, abilit...

Descripción completa

Detalles Bibliográficos
Autores principales: Romanazzo, Sara, Nemec, Stephanie, Roohani, Iman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696162/
https://www.ncbi.nlm.nih.gov/pubmed/31374871
http://dx.doi.org/10.3390/ma12152453
_version_ 1783444205653196800
author Romanazzo, Sara
Nemec, Stephanie
Roohani, Iman
author_facet Romanazzo, Sara
Nemec, Stephanie
Roohani, Iman
author_sort Romanazzo, Sara
collection PubMed
description Here, we present a concise review of current 3D bioprinting technologies applied to induced pluripotent stem cells (iPSC). iPSC have recently received a great deal of attention from the scientific and clinical communities for their unique properties, which include abundant adult cell sources, ability to indefinitely self-renew and differentiate into any tissue of the body. Bioprinting of iPSC and iPSC derived cells combined with natural or synthetic biomaterials to fabricate tissue mimicked constructs, has emerged as a technology that might revolutionize regenerative medicine and patient-specific treatment. This review covers the advantages and disadvantages of bioprinting techniques, influence of bioprinting parameters and printing condition on cell viability, and commonly used iPSC sources, and bioinks. A clear distinction is made for bioprinting techniques used for iPSC at their undifferentiated stage or when used as adult stem cells or terminally differentiated cells. This review presents state of the art data obtained from major searching engines, including Pubmed/MEDLINE, Google Scholar, and Scopus, concerning iPSC generation, undifferentiated iPSC, iPSC bioprinting, bioprinting techniques, cartilage, bone, heart, neural tissue, skin, and hepatic tissue cells derived from iPSC.
format Online
Article
Text
id pubmed-6696162
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66961622019-09-05 iPSC Bioprinting: Where are We at? Romanazzo, Sara Nemec, Stephanie Roohani, Iman Materials (Basel) Review Here, we present a concise review of current 3D bioprinting technologies applied to induced pluripotent stem cells (iPSC). iPSC have recently received a great deal of attention from the scientific and clinical communities for their unique properties, which include abundant adult cell sources, ability to indefinitely self-renew and differentiate into any tissue of the body. Bioprinting of iPSC and iPSC derived cells combined with natural or synthetic biomaterials to fabricate tissue mimicked constructs, has emerged as a technology that might revolutionize regenerative medicine and patient-specific treatment. This review covers the advantages and disadvantages of bioprinting techniques, influence of bioprinting parameters and printing condition on cell viability, and commonly used iPSC sources, and bioinks. A clear distinction is made for bioprinting techniques used for iPSC at their undifferentiated stage or when used as adult stem cells or terminally differentiated cells. This review presents state of the art data obtained from major searching engines, including Pubmed/MEDLINE, Google Scholar, and Scopus, concerning iPSC generation, undifferentiated iPSC, iPSC bioprinting, bioprinting techniques, cartilage, bone, heart, neural tissue, skin, and hepatic tissue cells derived from iPSC. MDPI 2019-08-01 /pmc/articles/PMC6696162/ /pubmed/31374871 http://dx.doi.org/10.3390/ma12152453 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Romanazzo, Sara
Nemec, Stephanie
Roohani, Iman
iPSC Bioprinting: Where are We at?
title iPSC Bioprinting: Where are We at?
title_full iPSC Bioprinting: Where are We at?
title_fullStr iPSC Bioprinting: Where are We at?
title_full_unstemmed iPSC Bioprinting: Where are We at?
title_short iPSC Bioprinting: Where are We at?
title_sort ipsc bioprinting: where are we at?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696162/
https://www.ncbi.nlm.nih.gov/pubmed/31374871
http://dx.doi.org/10.3390/ma12152453
work_keys_str_mv AT romanazzosara ipscbioprintingwhereareweat
AT nemecstephanie ipscbioprintingwhereareweat
AT roohaniiman ipscbioprintingwhereareweat